Home | All results_reference

[RDF data]
Results Reference #106

Resource URI: http://static.linkedct.org/resource/results_reference/106
linkedct:citation Baer MR, George SL, Caligiuri MA, et al.: Phase III study of immunotherapy with recombinant interleukin-2 (IL-2) versus no further therapy in acute myeloid leukemia (AML) patients  60 years in first complete remission (CALGB 9720). [Abstract] Blood 108 (11): A-424, 2006.
rdfs:label Results Reference #106
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00003190>
linkedct:results_reference_id 106 (xsd:int)
rdf:type linkedct:results_reference